Detection of rifabutin resistance and association ofrpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 2, 2002, Pages 143-145

  Heep, M ^a,b   Lehn, N ^a   Brandstatter B ^a   Rieger, U ^a   Senzenberger, S ^a   Wehrl, W ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; KRM 1657; METRONIDAZOLE; RIFABUTIN; RIFALAZIL; RIFAMPICIN; RIFAMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SENSITIVITY; GROWTH RATE; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TEMPERATURE;

DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; RIFABUTIN; RIFAMYCINS; SENSITIVITY AND SPECIFICITY;

EID: 0036192465     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-001-0672-2     Document Type: Article

References (11)

1. Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: Preliminary experience
2. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens
3. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies
4. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy
5. In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657
6. Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins
7. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates
8. The E test for antimicrobial susceptibility testing of Helicobacter pylori
9. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori
10. Compensatory evolution in rifampin-resistant Escherichia coli
11. Letter to the editors: Rifabutin-based Helicobacter pylori eradication 'rescue therapy'